查詢結果分析
相關文獻
- Impact of National Health Insurance on the Survival Rate of Patients with Osteosarcoma in Taiwan: Review of 74 Patients
- 不同飼糧纖維含量餵飼臺灣黑豬及藍瑞斯母豬對繁殖性能及仔豬育成之影響
- Antibiotic Use in Public Hospitals in Taiwan after the Implementation of National Health Insurance
- 我國健保制度之變革
- 臺灣地區全民健康保險規劃現況
- 勞基法中退休制度的改進﹣﹣兼論退休、資遺與失業保險制度之整合
- 臺灣省民眾對全民健康保險的認知及參與意願之調查研究
- Evaluating the Effectiveness of the Coal Ash Artificial Reefs at Wan-Li, Northern Taiwan
- 記臺灣蘭科植物相新記錄種--緣毛松蘭
- 臺灣的氣候變化--氣溫和降水
頁籤選單縮合
題 名 | Impact of National Health Insurance on the Survival Rate of Patients with Osteosarcoma in Taiwan: Review of 74 Patients=臺灣全民健康保險對骨肉瘤病人存活率之影響--74位病人之回顧 |
---|---|
作 者 | 方璟文; 簡松雄; 林高田; 王國照; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷 期 | 20:5 2004.05[民93.05] |
頁 次 | 頁230-234 |
分類號 | 416.66、416.66 |
關鍵詞 | 全民健康保險; 骨肉瘤; 存活率; 臺灣; National health insurance; Osteosarcoma; Survival rate; Taiwan; |
語 文 | 英文(English) |
中文摘要 | 自 1990 年 5 月至 2001 年 5 月,我們共治療了 74 位高度惡性骨肉瘤的病人。年齡分佈為 7 歲至 63 歲,中數為 17 歲。台灣在1995年3月1日實施全民健康保險,在全民健康保險實施之前,兩年存活率為 46.9%,實施之後增加為 73.8%。5 年存活率也從 37.5% 增加至 63.6%。在我們的研究裡,不足夠的手術切割邊、對化療反應差、疾病較末期及治療不完整的病人,其預後都比較差。在全民健康保險實施之前,有 10 位病人無法接受完整的治療,主要是無法負擔醫療費用。全民健康保險實施之後,只有 3 位病人因為個人因素而無法接受完整的治療。化學治療的進步大大的提高了病人的存活率,而全民健康保險的實施讓病人可以無後顧之憂的完成昂貴的療程,包括術前化療、保肢手術及術後化療。全民健康保險提高了病人的就醫率而使早期骨肉瘤病人的數目增加,因而改善了骨肉瘤病人之存活率及提高了接受保肢手術的病人數。我們的結論是全民健康保險的實施明顯的改善了台灣骨肉瘤病人之存活率。 |
英文摘要 | The 2-year survival rate for high-grade osteosarcoma was 46.9% before the introduction of National Health Insurance (NHI) in Taiwan on March 1, 1995, but increased to 73.8% after the implementation of NHI. The 5-year survival rate also increased, from 37.5% to 63.6%. Between May 1990 and May 2001, 74 patients with high-grade osteosarcoma were treated at our hospital. Median age was 17 years (range, 7-63 years). Inadequate surgical margins, poor histologic response to chemotherapy, advanced stage of disease, and incomplete treatment were strongly associated with poor prognosis. Before NHI, 10 patients had incomplete treatment, mainly because of unaffordable medical fees. After NHI, only three patients had incomplete treatment, due to personal reasons. Patient survival improved dramatically with advances in multiagent chemotherapy, but it was the NHI that enabled patients to complete expensive treatment courses, including preoperative neoadjuvant chemotherapy, limb-salvage surgery, and postoperative adjuvant chemotherapy. The NHI also improved the accessibility of medical care, with more patients presenting in the early stages of disease and, as a result, it not only improved survival rate but also increased the number of patients undergoing limb-salvage surgery. We concluded that the NHI significantly improved the survival rate for patients with osteosarcoma in Taiwan. |
本系統中英文摘要資訊取自各篇刊載內容。